Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Caterina Musolino

Showing results (1-10 of 155) with videos related to

Pageof 16
Sort By:
Pathology, Research and Practice|August 28, 2020
Immune checkpoint inhibitors in multiple myeloma: A review of the literatureSantino Caserta, Vanessa Innao, Caterina Musolino, et al.
Oncology Reports|December 7, 2016
Immature myeloid-derived suppressor cells: A bridge between inflammation and cancer (Review)Caterina Musolino, Alessandro Allegra, Govanni Pioggia, et al.
Current Medicinal Chemistry|September 15, 2021
New Insights into Neuropeptides Regulation of the Immune System and Hemopoiesis: Effects on Hematologic MalignanciesAlessandro Allegra, Emanuela Sant'Antonio, Caterina Musolino, et al.
The Tohoku Journal of Experimental Medicine|May 14, 2019
Antiresorptive Agents and Anti-Angiogenesis Drugs in the Development of Osteonecrosis of the JawAlessandro Allegra, Vanessa Innao, Nicolina Pulvirenti, et al.
Recenti Progressi in Medicina|August 6, 2019
[Efficacy of conventional chemotherapy in a primary double-refractory IgM multiple myeloma.]Vanessa Innao, Alessandro Allegra, Andrea Gaetano Allegra, et al.
Advances in Protein Chemistry and Structural Biology|May 1, 2019
Relationship between mitofusin 2 and cancerAlessandro Allegra, Vanessa Innao, Andrea Gaetano Allegra, et al.
International Journal of Molecular Sciences|December 1, 2020
New Frontiers about the Role of Human Microbiota in Immunotherapy: The Immune Checkpoint Inhibitors and CAR T-Cell Therapy EraVanessa Innao, Andrea Gaetano Allegra, Caterina Musolino, et al.
Annals of Hematology|July 17, 2020
Coagulopathy and thromboembolic events in patients with SARS-CoV-2 infection: pathogenesis and management strategiesAlessandro Allegra, Vanessa Innao, Andrea Gaetano Allegra, et al.
Cancers|April 30, 2021
New Insights into YES-Associated Protein Signaling Pathways in Hematological Malignancies: Diagnostic and Therapeutic ChallengesAlessandro Allegra, Giovanni Pioggia, Vanessa Innao, et al.
Clinical Lymphoma, Myeloma & Leukemia|June 3, 2021
Genetic Heterogeneity in Chronic Myeloid Leukemia: How Clonal Hematopoiesis and Clonal Evolution May Influence Prognosis, Treatment Outcome, and Risk of Cardiovascular EventsEmanuela Sant'Antonio, Chiara Camerini, Vincenzo Rizzo, et al.
Pageof 16

Showing results (1-10 of 155) with videos related to

Sort By:
Pageof 16
Pathology, Research and Practice|August 28, 2020
Immune checkpoint inhibitors in multiple myeloma: A review of the literatureSantino Caserta, Vanessa Innao, Caterina Musolino, et al.
Oncology Reports|December 7, 2016
Immature myeloid-derived suppressor cells: A bridge between inflammation and cancer (Review)Caterina Musolino, Alessandro Allegra, Govanni Pioggia, et al.
Current Medicinal Chemistry|September 15, 2021
New Insights into Neuropeptides Regulation of the Immune System and Hemopoiesis: Effects on Hematologic MalignanciesAlessandro Allegra, Emanuela Sant'Antonio, Caterina Musolino, et al.
The Tohoku Journal of Experimental Medicine|May 14, 2019
Antiresorptive Agents and Anti-Angiogenesis Drugs in the Development of Osteonecrosis of the JawAlessandro Allegra, Vanessa Innao, Nicolina Pulvirenti, et al.
Recenti Progressi in Medicina|August 6, 2019
[Efficacy of conventional chemotherapy in a primary double-refractory IgM multiple myeloma.]Vanessa Innao, Alessandro Allegra, Andrea Gaetano Allegra, et al.
Advances in Protein Chemistry and Structural Biology|May 1, 2019
Relationship between mitofusin 2 and cancerAlessandro Allegra, Vanessa Innao, Andrea Gaetano Allegra, et al.
International Journal of Molecular Sciences|December 1, 2020
New Frontiers about the Role of Human Microbiota in Immunotherapy: The Immune Checkpoint Inhibitors and CAR T-Cell Therapy EraVanessa Innao, Andrea Gaetano Allegra, Caterina Musolino, et al.
Annals of Hematology|July 17, 2020
Coagulopathy and thromboembolic events in patients with SARS-CoV-2 infection: pathogenesis and management strategiesAlessandro Allegra, Vanessa Innao, Andrea Gaetano Allegra, et al.
Cancers|April 30, 2021
New Insights into YES-Associated Protein Signaling Pathways in Hematological Malignancies: Diagnostic and Therapeutic ChallengesAlessandro Allegra, Giovanni Pioggia, Vanessa Innao, et al.
Clinical Lymphoma, Myeloma & Leukemia|June 3, 2021
Genetic Heterogeneity in Chronic Myeloid Leukemia: How Clonal Hematopoiesis and Clonal Evolution May Influence Prognosis, Treatment Outcome, and Risk of Cardiovascular EventsEmanuela Sant'Antonio, Chiara Camerini, Vincenzo Rizzo, et al.
Pageof 16